OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Chest Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations	140
Indoor Air Pollution and Respiratory Health	66
Epidemiology of Chronic Obstructive Pulmonary Disease	52
Silicosis: An Update and Guide for Clinicians	51
Advances in the Treatment of Non–Small Cell Lung Cancer	49
Allergic Bronchopulmonary Aspergillosis	49
Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease	39
Diagnosis of Primary Ciliary Dyskinesia	32
Working in Smoke:	31
Pneumothorax	30
Sex Differences in Pulmonary Hypertension	24
The Respiratory Risks of Ambient/Outdoor Air Pollution	23
Pleural Tuberculosis	22
Coal Workers’ Pneumoconiosis and Other Mining-Related Lung Disease	22
Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension	21
Alpha-1 Antitrypsin Deficiency Associated COPD	17
Alternatives to Surgery for Early-Stage Non–Small Cell Lung Cancer	17
Advances in Treatment of Locally Advanced or Metastatic Non–Small Cell Lung Cancer	17
Advances in the Treatment of Stage III Non–Small Cell Lung Cancer	16
Respiratory Health Effects of Exposure to Cleaning Products	15
The Changing Nature of Wildfires	15
Biomarkers in Chronic Obstructive Pulmonary Disease	15
Pulmonary Hypertension in Left Heart Disease	14
Parapneumonic Effusion and Empyema	14
Adaptation and Maladaptation of the Right Ventricle in Pulmonary Vascular Diseases	14

The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation	14
Congenital Heart Disease-Associated Pulmonary Hypertension	14
Gender Differences in Critical Illness and Critical Care Research	13
Pleural Fluid Analysis	13
Screening for Occupational Lung Cancer	13
Sex Differences in Obstructive Sleep Apnea	13
Chylothorax and Pseudochylothorax	12
Smoking Cessation/Vaccinations	12
Nontuberculous Mycobacterial Infections in Cystic Fibrosis	11
Lung Function Testing in Chronic Obstructive Pulmonary Disease	11
Nontuberculous Mycobacteria	11
Occupational Contributions to Interstitial Lung Disease	11
Health Disparities in Environmental and Occupational Lung Disease	11
Microbiology and the Microbiome in Bronchiectasis	10
Interstitial Lung Disease in 2020	10
Medical Thoracoscopy	10
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease	9
Sleep Deficiency and Cardiometabolic Disease	9
Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease	9
The Need for Social and Environmental Determinants of Health Research to Understand and Intervene on Racial/Ethnic Disparities in Obstructive Sleep Apnea	9
Bronchiectasis in Childhood	9
Differences Between Men and Women with Chronic Obstructive Pulmonary Disease	9
Women and Lung Cancer	9
Preoperative Assessment and Perioperative Management of the Patient with Pulmonary Vascular Disease	8
Clinical Relevance and Management of “Pre–Interstitial Lung Disease”	8
The Role of Exercise Testing in Pulmonary Vascular Disease	8
Patient-Centered and Family-Centered Care in the Intensive Care Unit	8
Occupational Bronchiolitis	8
Update on Innate and Adaptive Immunity in Cystic Fibrosis	8
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease	8
Diagnosis and Evaluation of Bronchiectasis	8
Challenges Faced by Women with Cystic Fibrosis	8
Management of Connective Tissue Disease-Associated Interstitial Lung Disease	8
Sleep Deficiency, Sleep Apnea, and Chronic Lung Disease	8
Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease	8
Management of Malignant Pleural Effusions	8
Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome	8
Update on Climate Change	7
Sleep Deficiency in Young Children	7
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections	7
Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis	7
Indwelling Pleural Catheters	7
Integrative Omics to Characterize and Classify Pulmonary Vascular Disease	7
Supporting Professionals in Critical Care Medicine	7
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era	7
Future Directions in Bronchiectasis Research	7
Interstitial Lung Diseases and the Impact of Gender	7
Malignant Pleural Effusions	7
Management of Idiopathic Pulmonary Fibrosis	7
Sleep Deficiency	7

Pulmonary Arterial Hypertension Secondary to Drugs and Toxins	6
Chronic Obstructive Pulmonary Disease Pathogenesis	6
Pulmonary Considerations for Pregnant Women	6
Lung Cancer Staging	6
Coronavirus Disease-2019 in the Immunocompromised Host	6
Management of Mental Health in Cystic Fibrosis	6
Pulmonary Rehabilitation	6
Systemic Medications in Chronic Obstructive Pulmonary Disease	6
Sex Differences and the Role of Sex Hormones in Pulmonary Hypertension	6
Lung Transplant Procedure of Choice	6
Diagnosis and Management of Fibrotic Interstitial Lung Diseases	6
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice	6
Family Planning and Reproductive Health in Cystic Fibrosis	6
Breaking the Impasse	6
SARS-CoV-2 Infection and COVID-19 in Children	6
Survivorship After Critical Illness and Post-Intensive Care Syndrome	6
Alternatives to Surgery for Early-Stage Non–Small Cell Lung Cancer	6
Surgical Therapies for Chronic Obstructive Pulmonary Disease	6
Pulmonary Hypertension in Pregnancy	6
Management of Pneumothorax	6